ALDH1A1 and nasopharyngeal carcinoma: Univariate survival analysis (log-rank test) showed that the overall survival rates (OS) was significantly lower for NPC patients with higher clinical stages, metastasis, or elevated ALDH1A1 expression (P = 0.005, P < 0.001, P = 0.005, respectively, Figure 2E).